健脾抗癌方抗晚期胃癌化疗毒副反应及对CEA的影响  

Effect of Jianpi Kangai prescription on toxic and side effect and CEA in the late gastric cancer chemotherapy

作　　者：邢益阳[1] 翟金海[1] 

机构地区：[1]江苏省江阴市中医院肿瘤科,江苏江阴214400

出　　处：《中医药临床杂志》2015年第9期1257-1259,共3页Clinical Journal of Traditional Chinese Medicine

基　　金：江阴市中医院青年中医科学基金科技项目(项目编号:JY130904)

摘　　要：目的:评价健脾抗癌方对晚期胃癌患者的化疗毒副作反应及肿瘤标记物的影响。方法:对已确诊的晚期胃癌80例随机分为治疗组40例,对照组40例。其中治疗组采用健脾抗癌方联合化疗,对照组单纯化疗,8周后比较疗效。结果:2组患者中,治疗组在降低晚期胃癌患者癌胚抗原(CEA)值及化疗毒副反应中的白细胞减少、恶心呕吐等与单纯化疗相比有显著性差异。结论:健脾抗癌方在治疗晚期胃癌时增强化疗疗效、降低化疗引起的毒副反应,且耐受性良好,安全性高,可望为部分胃癌患者提供更有效的治疗方法。Objective： To evaluated the effect of Jianpi Kangai prescription on toxic and side effect and CEA in the late gastric cancer chemotherapy. Methods： 80 cases with advanced gastric carcinoma were randomly divided into the treatment group of 40 cases,40 cases of the control group. The treatment group were treated with Jianpi Kangai prescription com- bined with chemotherapy. Simple chemotherapy was used in the control group. Results： The two groups of patients, treat- ment group in the decrease of CEA value in patients with advanced gastric cancer and the side effects of chemotherapy, neutropenia, nausea and vomiting with chemotherapy alone compared with significant difference （P〈0.05）. Conclusion： Jianpi Kangai prescription enhance the efficacy of chemotherapy in the treatment of advanced gastric cancer, reduce the adverse reaction caused by chemotherapy, and good tolerance, high safety, is expected to provide more effective treatment methods for oatients with gastric cancer.

关 键 词：健脾抗癌方 晚期胃癌 化疗毒副反应 癌胚抗原 

分 类 号：R273[医药卫生—中西医结合]